Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 14, 2019 at 10:37 am EST
Share
Frélii, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 23,579 compared to USD 13,375 a year ago. Operating loss was USD 2.479 million compared to USD 1.103 million a year ago. Net loss was USD 2.486 million compared to USD 2.262 million a year ago. For the nine months, sales was USD 63,126 compared to USD 17,116 a year ago. Operating loss was USD 4.262 million compared to USD 4.153 million a year ago. Net loss was USD 4.271 million compared to USD 5.309 million a year ago.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
FRÉLII, INC. 
